TREATMENT PLAN, PROGNOSIS, KEY INFORMATION
TREATMENT PLAN
Non-pregnant individuals:
- Stay home for 5 days post-rash development
- Avoid pregnant women
- Avoid school/work/activities
- Simple supportive measures
Pregnant individuals:
- Early referral if high-risk
- MMR vaccination (2 doses) for prevention of pre-pregnancy
PROGNOSIS
Non-immune pregnant women:
- <20 weeks (especially <8-10 weeks): increased risk of:
- Multiple congenital defects
- Cardiac abnormalities
- Cataracts
- Hearing impairments
- Intrauterine growth retardation
- Diabetes
- Thyroid issues
- Autism
- Microcephaly
- Stillbirth
- Miscarriage
- >22 weeks: no documented risk of congenital rubella syndrome
KEY INFORMATION
- Notifiable disease (unlike parvovirus B19)
- Part of the MMR vaccine (live vaccine)
- Positive serology indicates immunity
- Symptoms usually resolve within 1 week in non-pregnant cases
The severity of congenital rubella syndrome depends on gestational age at infection EXTRA’S
- Symptoms can be indistinguishable from parvovirus B19.